(Q44797813)

6 December 2017

title

Treatments for bipolar disorder: can number needed to treat/harm help inform clinical decisions? (English)

1 reference

6 December 2017

1 reference

2

1 reference

6 December 2017

T A Ketter

1

1 reference

6 December 2017

P W Wang

series ordinal

3

1 reference

6 December 2017

J L Culver

series ordinal

4

1 reference

6 December 2017

S Srivastava

series ordinal

5

1 reference

6 December 2017

language of work or name

English

0 references

publication date

7 December 2010

1 reference

Acta Psychiatrica Scandinavica

6 December 2017

published in

1 reference

6 December 2017

volume

123

1 reference

6 December 2017

issue

3

1 reference

6 December 2017

page(s)

175-189

1 reference

Teaching the philosophy and tools of evidence-based medicine: misunderstandings and solutions.

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2010.01645.X

Reporting outcomes in clinical trials for bipolar disorder: a commentary and suggestions for change.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2010.01645.X

Compelling or irrelevant? Using number needed to treat can help decide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2010.01645.X

Quantifying risk: the role of absolute and relative measures in interpreting risk of adverse reactions from product labels of antipsychotic medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2010.01645.X

Antipsychotics for the treatment of schizophrenia: likelihood to be helped or harmed, understanding proximal and distal benefits and risks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2010.01645.X

Evidence based medicine: what it is and what it isn't

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2010.01645.X

Size of treatment effects and their importance to clinical research and practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2010.01645.X

Confidence intervals for the number needed to treat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2010.01645.X

Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2010.01645.X

Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2010.01645.X

Risperidone in the treatment of acute mania: double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2010.01645.X

Quetiapine or haloperidol as monotherapy for bipolar mania--a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2010.01645.X

Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2010.01645.X

Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2010.01645.X

A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2010.01645.X

Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2010.01645.X

Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2010.01645.X

Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2010.01645.X

Quetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2010.01645.X

Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate/lithium monotherapy: a placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2010.01645.X

Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2010.01645.X

A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2010.01645.X

Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2010.01645.X

Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2010.01645.X

Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2010.01645.X

A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2010.01645.X

Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2010.01645.X

Maintenance treatment for patients with bipolar I disorder: results from a north american study of quetiapine in combination with lithium or divalproex (trial 127).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2010.01645.X

Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2010.01645.X

A 3-week, randomized, placebo-controlled trial of asenapine in the treatment of acute mania in bipolar mania and mixed states

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2010.01645.X

Asenapine in the treatment of acute mania in bipolar I disorder: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2010.01645.X

Ziprasidone plus a mood stabilizer in subjects with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2010.01645.X

A randomized controlled study of cognitive therapy for relapse prevention for bipolar affective disorder: outcome of the first year

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2010.01645.X

Effects of lamotrigine and lithium on body weight during maintenance treatment of bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2010.01645.X

Effectiveness of adjunctive antidepressant treatment for bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2010.01645.X

Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2010.01645.X

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2010.01645.X

Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2010.01645.X

Lithium treatment -- moderate dose use study (LiTMUS) for bipolar disorder: rationale and design

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2010.01645.X

Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2010.01645.X

Atypical antipsychotics in bipolar disorder: systematic review of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2010.01645.X

Reviewing CATIE for clinicians: balancing benefit and risk using evidence-based medicine tools

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2010.01645.X

Individualizing treatment decisions. The likelihood of being helped or harmed

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2010.01645.X

Communicating the benefits and harms of treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2010.01645.X

A Randomized Trial on the Efficacy of Group Psychoeducation in the Prophylaxis of Recurrences in Bipolar Patients Whose Disease Is in Remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2010.01645.X

10.1111/J.1600-0447.2010.01645.X

21 January 2018

Identifiers

DOI

1 reference

6 December 2017

1 reference